Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Advanced Pancreatic Cancer × Radiosurgery × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 40 Prostatic Neoplasms 30 Pancreatic Neoplasms 25 Brain Neoplasms 24 Lung Neoplasms 23 Neoplasm Metastasis 20 Melanoma 19 Carcinoma, Hepatocellular 16 Breast Neoplasms 15 Carcinoma, Renal Cell 11 Colorectal Neoplasms 9 Squamous Cell Carcinoma of Head and Neck 8 Neoplasms 8 Small Cell Lung Carcinoma 7 Recurrence 5 Glioblastoma 5 Urinary Bladder Neoplasms 4 Sarcoma 4 Liver Neoplasms 4 Kidney Neoplasms 4 Adenocarcinoma of Lung 4 Uterine Cervical Neoplasms 3 Clear-cell metastatic renal cell carcinoma 3 Cholangiocarcinoma 3 Uveal Melanoma 2 Unresectable Locally Recurrent Rectal Cancer 2 Rectal Neoplasms 2 Ovarian Neoplasms 2 Osteosarcoma 2 NSCLC 2

Interventions

Gemcitabine 5 Taxes 2 Drug Therapy 2 Albumin-Bound Paclitaxel 2 130-nm albumin-bound paclitaxel 2 toripalimab 1 nimotuzumab 1 irinotecan sucrosofate 1 envafolimab 1 endostar protein 1 cabiralizumab 1 apatinib 1 S 1 (combination) 1 Radiosurgery 1 Oxaliplatin 1 Nivolumab 1 Leucovorin 1 Irinotecan 1 Immunotherapy 1 IMM-101 1 Fluorouracil 1 Endostatins 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06422156 2024-05-20

Nim-PC-28

Peking University Third Hospital

Phase 2 Not yet recruiting

Gastrointestinal

Advanced Pancreatic Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡